Aevice Health obtains $1M investment for Japan, US expansion
Singapore-based respiratory health IT maker Aevice Health has received a $1 million investment from A&D Company for its expansion in the United States and Japan.
Based on their agreement, Aevice can leverage the sales network of its investor, which manufactures precision equipment and product inspection equipment for healthcare and...
The Bipartisan Senate AI Working Group released a roadmap for AI policy in the U.S. Senate, encouraging the Senate Appropriations Committee to fund cross-government artificial intelligence research and development projects, including research for biotechnology and applications of AI that would fundamentally transform medicine.
The group acknowledges AI's various use cases, including those within...
Seoul-based medical equipment maker Samsung Medison has recently agreed to fully purchase Sonio, a foetal ultrasound AI company in France, for 126 billion won ($92 million).
The four-year-old French startup has been developing IT solutions for obstetrics and gynaecology ultrasound, assisting medical professionals in documenting and evaluating ultrasound examinations.
Last year, it obtained the...
GenAI radiology workflow company Rad AI announced it secured $50 million in Series B funding led by Khosla Ventures, bringing the company's total raise to more than $80 million.
WiL (World Innovation Lab) participated in the round, alongside existing investors OCV Partners, Gradient Ventures (Google's AI-focused fund), Kickstart Fund and ARTIS Ventures.
Rad AI offers radiologists generative AI...
A mobile application used to assess sports-related head and brain injuries is now being tested for detecting and monitoring neurological disorders.
BrainEye's mobile test is now being studied in clinical trials at The Alfred Hospital in Melbourne. It digitises the traditional eye movement test, which is done in 60 seconds through a mobile device, and then collects and measures over 20 ocular...
AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, developed more than a decade ago, allows scientists to modify DNA sequences within...
The head of Microsoft's AI for Good Lab, Juan Lavista Ferres, coauthored a book providing real-world examples of how artificial intelligence can responsibly be used to positively affect humankind.
Ferres sat down with MobiHealthNews to discuss his new book, AI for Good: Applications in Sustainability, Humanitarian Action and Health. He talked about ways to mitigate biases within data input in AI...
OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant's employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.
Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also...
Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital.
The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead investors in the funding round.
Lux Capital, Two Sigma Ventures, F-Prime, Rsquared, SV Angel, Menlo Ventures, Sequoia Capital, NEA, the Parker Institute for...
Prior authorization automation platform Cohere Health and health insurer Humana announced they are expanding their 2021 partnership, which focused on the prior authorization process for musculoskeletal issues, to include diagnostic imaging and sleep services.
The Cohere Unify Platform leverages AI to accelerate the prior authorization process by using predictive technology and clinical...
